Detalhe da pesquisa
1.
Identification of a Notch transcriptomic signature for breast cancer.
Breast Cancer Res
; 26(1): 4, 2024 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172915
2.
Roles of Notch Signaling in the Tumor Microenvironment.
Int J Mol Sci
; 23(11)2022 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35682918
3.
NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Breast Cancer Res
; 20(1): 105, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30180881
4.
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial.
JAMA Oncol
; 9(6): 815-824, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892847
5.
Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.
J Biol Chem
; 285(40): 30443-52, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20663877
6.
Spectroscopic label-free microscopy of changes in live cell chromatin and biochemical composition in transplantable organoids.
Sci Adv
; 7(34)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407934
7.
Aurora-A kinase oncogenic signaling mediates TGF-ß-induced triple-negative breast cancer plasticity and chemoresistance.
Oncogene
; 40(14): 2509-2523, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674749
8.
Aurora-A overexpression is linked to development of aggressive teratomas derived from human iPS cells.
Oncol Rep
; 39(4): 1725-1730, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29393405
9.
Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells.
Oncotarget
; 8(53): 91803-91816, 2017 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29207686
10.
Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor.
Circ Res
; 90(2): 128-34, 2002 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-11834704
11.
Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint.
Oncogene
; 23(23): 4068-75, 2004 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15064746
12.
Aurora-A Kinase as a Promising Therapeutic Target in Cancer.
Front Oncol
; 5: 295, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26779440
13.
Inhibition of Cdk2 kinase activity selectively targets the CD44âº/CD24â»/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
Int J Oncol
; 45(3): 1193-9, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24970653
14.
Targeting breast cancer initiating cells: advances in breast cancer research and therapy.
Adv Biol Regul
; 56: 81-107, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24913694
15.
Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells.
PLoS One
; 9(5): e96995, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24816249
16.
GSK-3 as potential target for therapeutic intervention in cancer.
Oncotarget
; 5(10): 2881-911, 2014 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24931005
17.
Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.
Oncol Rep
; 29(5): 1785-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23446853
18.
Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells.
Int J Oncol
; 40(6): 1858-64, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22447278
19.
Centrosome amplification and the development of cancer.
Oncogene
; 21(40): 6146-53, 2002 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-12214243
20.
Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.
Int J Oncol
; 37(5): 1167-76, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20878064